Langerhans cell histiocytosis: Malignancy or inflammatory disorder doing a great job of imitating one?

DMM Disease Models and Mechanisms

Volumn 2, Issue 9-10, 2009, Pages 436-439

  Degar, Barbara A ^a,b,d   Rollins, Barrett J ^a,c,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CORTICOSTEROID DERIVATIVE; MERCAPTOPURINE; PREDNISONE; PROTEIN P53; VINBLASTINE;

ANTIGEN PRESENTING CELL; BALANCE DISORDER; BONE BIOPSY; BONE LESION; CELL MATURATION; CELL PROLIFERATION; CLINICAL FEATURE; DIABETES INSIPIDUS; DYSDIADOCHOKINESIA; EPIDERMIS; EPIGENETICS; EXOPHTHALMOS; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; GENETIC DISORDER; GENOMICS; HISTIOCYTOSIS X; HUMAN; HYPOPITUITARISM; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LANGERHANS CELL; MASTOIDITIS; MORTALITY; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS MEDIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RARE DISEASE; RASH; REVIEW; TREMOR;

ANIMALS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; MALE; PREGNANCY;

ANIMALIA;

EID: 70450200754     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.004010     Document Type: Review

References (38)

1. Affolter, V. K. and Moore, P. F. (2000). Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am. J. Dermatopathol. 22, 40-48.
2. Annels, N. E., da Costa, C. E. T., Prins, F. A., Willemze, A., Hogendoorn, P. C. W. and Egeler, R. M. (2003). Aberrant chemokine receptor expression and chemokine production by langerhans cells underlies the pathogenesis of langerhans cell histiocytosis. J. Exp. Med. 197, 1385-1390. (Pubitemid 36617785)
3. Arico, M., Nichols, K., Whitlock, J. A., Arceci, R., Haupt, R., Mittler, U., Kuhne, T., Lombardi, A., Ishii, E., Egeler, R. M. et al. (1999). Familial clustering of Langerhans cell histiocytosis. Br. J. Haematol. 107, 883-888. (Pubitemid 30020164)
4. Betts, D. R., Leibundgut, K. E., Feldges, A., Pluss, H. J. and Niggli, F. K. (1998). Cytogenetic abnormalities in Langerhans cell histiocytosis. Br. J. Cancer 77, 552-555. (Pubitemid 28059460)
5. Bonkobara, M., Yudate, T., Yagihara, H., Washizu, T., Cruz, P. D., Jr and Ariizumi, K. (2004). Transcriptional regulation of dectin-2 promoter in transgenic mouse. J. Vet. Med. Sci. 66, 1483-1489. (Pubitemid 41380174)
6. Braier, J., Latella, A., Balancini, B., Castanos, C., Rosso, D., Chantada, G., Ripoli, M. and Goldberg, J. (2004). Outcome in children with pulmonary Langerhans cell Histiocytosis. Pediatr. Blood Cancer 43, 765-769. (Pubitemid 39557713)
7. Capanna, R., Springfield, D. S., Ruggieri, P., Biagini, R., Picci, P., Bacci, G., Giunti, A., Lorenzi, E. G. and Campanacci, M. (1985). Direct cortisone injection in eosinophilic granuloma of bone: a preliminary report on 11 patients. J. Pediatr. Orthop. 5, 339-342. (Pubitemid 15117329)
8. Chikwava, K. R., Hunt, J. L., Mantha, G. S., Murphy, J. E. and Jaffe, R. (2007). Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis. Pediatr. Dev. Pathol. 10, 18-24. (Pubitemid 350177697)
9. Cohen, M., Zornoza, J., Cangir, A., Murray, J. A. and Wallace, S. (1980). Direct injection of methylprednisolone sodium succinate in the treatment of solitary eosinophilic granuloma of bone: a report of 9 cases. Radiology 136, 289-293. (Pubitemid 10044735)
10. da Costa, C. E., Szuhai, K., van Eijk, R., Hoogeboom, M., Sciot, R., Mertens, F., Bjorgvinsdottir, H., Debiec-Rychter, M., de Krijger, R. R., Hogendoorn, P. C. et al. (2009). No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer 48, 239-249.
11. Degar, B. A., Fleming, M. D. and Rollins, B. (2009). Histiocytoses. In Nathan and Oski's Hematology of Infancy and Childhood (ed. S. H. Orkin, D. E. Fishier, A. T. Look, S. E. Lux, 4th, D. Ginsburg, and D. G. Nathan). Philadelphia, PA: Elsevier.
12. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S. and Caux, C. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386. (Pubitemid 28357765)
13. Emile, J. F., Fraitag, S., Leborgne, M., de Prost, Y. and Brousse, N. (1994). Langerhans' cell histiocytosis cells are activated Langerhans' cells. J. Pathol. 174, 71-76. (Pubitemid 24318449)
14. Fleming, M. D., Pinkus, J. L., Alexander, S. W., Tam, C., Loda, M., Sallan, S. E., Nichols, K. E., Carpentieri, D. F., Pinkus, G. S. and Rollins, B. J. (2003). Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 101, 2473-2475. (Pubitemid 36857600)
15. Gadner, H., Heitger, A., Grois, N., Gatterer-Menz, I. and Ladisch, S. (1994). Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med. Pediatr. Oncol. 23, 72-80.
16. Gadner, H., Grois, N., Potschger, U., Minkov, M., Arico, M., Braier, J., Broadbent, V., Donadieu, J., Henter, J. I., McCarter, R. et al. (2008). Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111, 2556-2562.
17. Geissmann, F., Emile, J. F., Andry, P., Thomas, C., Fraitag, S., De Prost, Y. and Brousse, N. (1997). Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J. Pathol. 181, 301-304. (Pubitemid 27156843)
18. Gogusev, J., Telvi, L., Murakami, I., Lepelletier, Y., Nezelof, C., Stojkoski, A., Glorion, C. and Jaubert, F. (2005). DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone. Pediatr. Blood Cancer 44, 128-137. (Pubitemid 40041528)
19. Grois, N., Prayer, D., Prosch, H. and Lassmann, H. (2005). Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128, 829-838. (Pubitemid 40516920)
20. Guyot-Goubin, A., Donadieu, J., Barkaoui, M., Bellec, S., Thomas, C. and Clavel, J. (2008). Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr. Blood Cancer 51, 71-75. (Pubitemid 351717393)
21. Ha, S. Y., Helms, P., Fletcher, M., Broadbent, V. and Pritchard, J. (1992). Lung involvement in Langerhans' cell histiocytosis: prevalence, clinical features, and outcome. Pediatrics 89, 466-469.
22. Janka, G., Imashuku, S., Elinder, G., Schneider, M. and Henter, J. I. (1998). Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North Am. 12, 435-444. (Pubitemid 28175891)
23. Jeziorski, E., Senechal, B., Molina, T. J., Devez, F., Leruez-Ville, M., Morand, P., Glorion, C., Mansuy, L., Gaudelus, J., Debre, M. et al. (2008). Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS ONE 3, e3262.
24. Kammertoens, T., Willebrand, R., Erdmann, B., Li, L., Li, Y., Engels, B., Uckert, W. and Blankenstein, T. (2005). CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells. Cancer Res. 65, 2560-2564. (Pubitemid 40490051)
25. Minkov, M., Grois, N., Heitger, A., Potschger, U., Westermeier, T. and Gadner, H. (2000). Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin. Padiatr. 212, 139-144.
26. Murakami, I., Gogusev, J., Fournet, J. C., Glorion, C. and Jaubert, F. (2002). Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone. Hum. Pathol. 33, 555-560. (Pubitemid 34747877)
27. Murray, S., Rowlinson-Busza, G., Morris, J. F. and Chu, A. C. (2000). Diagnostic and therapeutic evaluation of an anti-Langerhans cell histiocytosis monoclonal antibody (NA1/34) in a new xenograft model. J. Invest. Dermatol. 114, 127-134.
28. Nezelof, C., Basset, F. and Rousseau, M. F. (1973). Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine 18, 365-371.
29. Odame, I., Li, P., Lau, L., Doda, W., Noseworthy, M., Babyn, P. and Weitzman, S. (2006). Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Pediatr. Blood Cancer 47, 889-893.
30. Padgett, G. A., Madewell, B. R., Keller, E. T., Jodar, L. and Packard, M. (1995). Inheritance of histiocytosis in Bernese mountain dogs. J. Small Anim. Pract. 36, 93-98.
31. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S. and Lanzavecchia, A. (1998). Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
32. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R. and Mantovani, A. (1998). Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161, 1083-1086.
33. Steiner, Q. G., Otten, L. A., Hicks, M. J., Kaya, G., Grosjean, F., Saeuberli, E., Lavanchy, C., Beermann, F., McClain, K. L. and Acha-Orbea, H. (2008). In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis. Blood 111, 2073-2082.
34. Stossel, H., Koch, F., Kampgen, E., Stoger, P., Lenz, A., Heufler, C., Romani, N. and Schuler, G. (1990). Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 172, 1471-1482.
35. Tazi, A., Moreau, J., Bergeron, A., Dominique, S., Hance, A. J. and Soler, P. (1999). Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J. Immunol. 163, 3511-3515. (Pubitemid 29431857)
36. Weintraub, M., Bhatia, K. G., Chandra, R. S., Magrath, I. T. and Ladisch, S. (1998). p53 expression in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 20, 12-17. (Pubitemid 28119750)
37. Willman, C. L., Busque, L., Griffith, B. B., Favara, B. E., McClain, K. L., Duncan, M. H. and Gilliland, D. G. (1994). Langerhans'-cell histiocytosis (histiocytosis X)- a clonal proliferative disease. N. Engl. J. Med. 331, 154-160. (Pubitemid 24209565)
38. Yu, R. C., Chu, C., Buluwela, L. and Chu, A. C. (1994). Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343, 767-768.